A detailed history of Capital Advisors, Ltd. LLC transactions in Incyte Corp stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 258 shares of INCY stock, worth $18,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
258
Previous 260 0.77%
Holding current value
$18,503
Previous $16,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$57.33 - $68.61 $114 - $137
-2 Reduced 0.77%
258 $17,000
Q2 2024

Jul 25, 2024

BUY
$51.18 - $63.75 $13,306 - $16,575
260 New
260 $16,000
Q2 2023

Jul 26, 2023

SELL
$60.95 - $75.51 $609 - $755
-10 Reduced 43.48%
13 $1,000
Q1 2023

May 03, 2023

SELL
$70.23 - $86.01 $210 - $258
-3 Reduced 11.54%
23 $2,000
Q4 2022

Feb 07, 2023

BUY
$67.18 - $84.11 $1,746 - $2,186
26 New
26 $2,000
Q1 2022

May 09, 2022

BUY
$66.02 - $79.71 $66 - $79
1 Added 12.5%
9 $1,000
Q4 2021

Feb 08, 2022

BUY
$63.34 - $74.11 $506 - $592
8 New
8 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.